Title : Keeping up with the therapeutic advances in schizophrenia: a review of novel and emerging pharmacological entities.

Pub. Date : 2019 Aug

PMID : 31482779






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Therapies targeting residual positive symptoms/treatment-resistant schizophrenia include pimavanserin, dopamine D1/D2 antagonist LuAF-35700, and DAAO inhibitor sodium benzoate. Sodium Benzoate D-amino acid oxidase Homo sapiens